OXYCONTIN HAT - AN OVERVIEW

Within a 2004 letter for the FDA, Purdue attorneys claimed the company prepared to continue advertising OxyContin to Medical practitioners to be a twelve-hour drug for various explanations, which includes "competitive gain."They went on to make a case considerably diverse than the one Purdue income reps were earning to Medical professionals. 8-hour